Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

Presentation TVT 2023

SPOTLIGHT LECTURE: Failed TAVR Management -Lessons Learned From Registry Experiences

Presenter: Uri Landes

June 10, 2023

Presentation TVT 2023

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Presenter: Mayra Guerrero

June 10, 2023

Presentation TVT 2023

Case Presentation 3: Favoring TAVR Explant: When to Throw in the Towel and Operate

Presenter: Keith Allen

June 10, 2023

Presentation TVT 2023

Case Presentation 2: Failed Annular TAVR and ‘How To Do’ TAV-in-TAV (e.g. With BASILICA in Sapien)

Presenter: Jaffar Khan

June 10, 2023

Presentation TVT 2023

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

Presenter: Sachin Goel

June 10, 2023

Presentation TVT 2023

TAVR Failure Modes, Anatomic Considerations and New Nomenclature for TAV-in-TAV Procedures

Presenter: Gilbert Tang

June 10, 2023

Presentation TVT 2023

Safety and Efficacy of M-TEER in PMR: Insights From the STS/ACC TVT Registry

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

M-TEER Outcomes in Real-World PMR Patients: The PRIME-MR Registry

Presenter: Augustin Coisne

June 08, 2023

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2023

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

Counterpoint: Not Ready Yet – Ensuring Reproducible ‘Surgical-Like’ Results Needs to be Demonstrated First!

Presenter: Thomas Modine

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Planning for the 2nd Valve Before Placing the First One: Anatomic Considerations in Treating Patients With Long Life Expectancy

Presenter: Janarthanan Sathananthan

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: TEER in Primary MR - Clinical Evidence, Indications, and Controversies

Presenter: Charles Davidson

June 08, 2023

Presentation TVT 2023

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

Presenter: Sammy Elmariah

June 08, 2023

Presentation TVT 2023

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

Advertisement

SPOTLIGHT LECTURE: Failed TAVR Management -Lessons Learned From Registry Experiences

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Case Presentation 3: Favoring TAVR Explant: When to Throw in the Towel and Operate

Case Presentation 2: Failed Annular TAVR and ‘How To Do’ TAV-in-TAV (e.g. With BASILICA in Sapien)

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

TAVR Failure Modes, Anatomic Considerations and New Nomenclature for TAV-in-TAV Procedures

Safety and Efficacy of M-TEER in PMR: Insights From the STS/ACC TVT Registry

M-TEER Outcomes in Real-World PMR Patients: The PRIME-MR Registry

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Counterpoint: Not Ready Yet – Ensuring Reproducible ‘Surgical-Like’ Results Needs to be Demonstrated First!

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

SPOTLIGHT LECTURE: Planning for the 2nd Valve Before Placing the First One: Anatomic Considerations in Treating Patients With Long Life Expectancy

SPOTLIGHT LECTURE: TEER in Primary MR - Clinical Evidence, Indications, and Controversies

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content